IDO Idmos

RNS Number:9328X
IDMoS plc
07 June 2007


For immediate release                                       7 June 2007



                      IDMoS plc ("IDMoS" or the "Company")
                Fundraising to raise #2 million before expenses
                 by the issue of 5,714,287 new Ordinary Shares

IDMoS plc (AIM: IDO), the specialist in disease detection and monitoring
technology, today announces the conditional fundraising (the "Fundraising") of
#2 million before expenses. The Fundraising consists of the conditional placing
of 5,257,145 ordinary shares of 5p each at 35 pence per share (the "Placing")
and a conditional subscription (including a subscription by certain of the
Directors) for 457,142 ordinary shares in aggregate at 35 pence per share. The
new Ordinary Shares to be issued pursuant to the Fundraising, represent
approximately 31.1 per cent of the current issued ordinary share capital of the
Company. The new Ordinary Shares to be issued pursuant to the Placing have been
placed by Nomura Code Securities Limited, on behalf of the Company, with new and
existing institutional investors.

The net proceeds of the Fundraising will be used to meet the further funding
requirement for the launch of the Company's initial dental products, the CDD
("Caries Detection Device") and the CMSS ("Caries Management Support System"),
for which sales for the US and European markets are expected to be made later
this year. Following the successful launch of these products, it is intended to
progress further the development of the 3D CMSS during 2008.

It is intended to appoint Roger McDowell and Malcolm Gillies as non-executive
directors with effect from the board meeting scheduled for 20 June 2007.

The Fundraising is conditional, inter alia, on admission of the new Ordinary
Shares to trading on AIM and the approval by shareholders of certain resolutions
to be proposed at an Extraordinary General Meeting to be held by the Company on
2 July 2007. A circular will be sent to shareholders shortly together with the
notice of EGM.

Application will be made for the new Ordinary Shares to be admitted to trading
on AIM and it is expected that trading in the new Ordinary Shares, which will
rank from Admission pari passu in all respects with the existing ordinary shares
in the Company, will commence on AIM by 3 July 2007.

It is expected that, following the issue of the new Ordinary Shares, the
enlarged share capital of the Company will comprise 24,073,212 ordinary shares
of 5p each.

Stephen Westwood, Chief Executive, said:

"I would like to thank all of those investors who are supporting us in this
Fundraising. The launch of the initial dental products is a crucial step in our
business progression."


                                      ENDS


For further information, please contact:
IDMoS plc
Stephen Westwood                                           01382 598440

Buchanan Communications
Tim Anderson/Isobel Podda                                 020 7466 5000



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCFFMLTMMAMBBR

Idmos (LSE:IDO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Idmos (LSE:IDO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024